Skip to main content

Peer Review reports

From: Prolonged 14-day continuous infusion of high-dose ifosfamide for patients with relapsed and refractory high-grade osteosarcoma: a retrospective multicentre cohort study

Original Submission
10 Feb 2024 Submitted Original manuscript
25 Feb 2024 Reviewed Reviewer Report - L. Xie
26 Feb 2024 Reviewed Reviewer Report
28 Feb 2024 Reviewed Reviewer Report - Hiroshi Urakawa
29 Feb 2024 Reviewed Reviewer Report - Takashi Higuchi
12 Mar 2024 Reviewed Reviewer Report
14 Mar 2024 Reviewed Reviewer Report
23 Apr 2024 Author responded Author comments - Anna Campello
Resubmission - Version 2
23 Apr 2024 Submitted Manuscript version 2
2 May 2024 Author responded Author comments - Anna Campello
Resubmission - Version 3
2 May 2024 Submitted Manuscript version 3
7 May 2024 Reviewed Reviewer Report - Hiroshi Urakawa
16 May 2024 Reviewed Reviewer Report - Takashi Higuchi
5 Jun 2024 Author responded Author comments - Anna Campello
Resubmission - Version 4
5 Jun 2024 Submitted Manuscript version 4
8 Jun 2024 Reviewed Reviewer Report - Takashi Higuchi
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
10 Jun 2024 Editorially accepted
19 Jun 2024 Article published 10.1186/s12885-024-12498-x

You can find further information about peer review here.

Back to article page